OncoQuest Pharmaceuticals

OncoQuest Pharmaceuticals Inc. is a South Korean biopharmaceutical company focused on the development and commercialization of cancer immunotherapies. OncoQuest Pharmaceuticals' technology platform includes a series of tumor antigen-specific monoclonal immunoglobulins targeting CA-125, MUC1, PSA, and Her2/neu.